Clinical Trial Update: Evaluation of Oncoxin-Viusid® in Head and Neck Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Oncoxin-Viusid in head and neck cancer, indicating the study has completed its Phase 2 evaluation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Oncoxin-Viusid

Snippet

Sponsor: Catalysis SL | Conditions: Head Cancer Neck | Phase 2 | Status: COMPLETED